| Patent application number | Description | Published |
|---|
| 20080293634 | C-MET RECEPTOR REGULATION BY ANGIOTENSIN IV (AT4) RECEPTOR LIGANDS - The cell surface c-Met receptor, through which hepatocyte growth factor (HGF) signals are mediated, has now been identified as the Angiotensin-IV receptor (AT(4)R) in processes that include HGF-regulated cell motility, angiogenesis, cancer metastasis, adipogenesis and others. Disclosed are angiotensin-like factor compositions and methods for using them to diagnose, prevent and/or treat conditions associated with c-Met dysregulation, including cancer, obesity and conditions associated with obesity, and other disorders, for example, by altering hepatocyte growth factor activity or c-Met receptor activity by administering an angiotensin-like factor that specifically binds to a cell surface c-Met receptor. | 11-27-2008 |
| 20130023475 | C-MET RECEPTOR REGULATION BY ANGIOTENSIN IV (AT4) RECEPTOR LIGANDS - The cell surface c-Met receptor, through which hepatocyte growth factor (HGF) signals are mediated, has now been identified as the Angiotensin-IV receptor (AT(4)R) in processes that include HGF-regulated cell motility, angiogenesis, cancer metastasis, adipogenesis and others. Disclosed are angiotensin-like factor compositions and methods for using them to diagnose, prevent and/or treat conditions associated with c-Met dysregulation, including cancer, obesity and conditions associated with obesity, and other disorders, for example, by altering hepatocyte growth factor activity or c-Met receptor activity by administering an angiotensin-like factor that specifically binds to a cell surface c-Met receptor. In addition, members of this group of molecules may useful for treating or preventing the development of neurodegenerative diseases like general dementia, Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis and initiating recovery from traumatic brain injury and spinal cord trauma. These peptides and peptidomimetics may be therapeutically useful whenever increased neurotrophic activity would be clinically advantageous. | 01-24-2013 |
| Patent application number | Description | Published |
|---|
| 20090320975 | PERCHLORATE-FREE GREEN SIGNAL FLARE COMPOSITION - Perchlorate-free green flare compositions are disclosed which, when burned, produce green smoke and flames. Methods of producing the compositions are also disclosed. | 12-31-2009 |
| 20090320976 | PERCHLORATE-FREE YELLOW SIGNAL FLARE COMPOSITION - Perchlorate-free flare compositions are disclosed which, when burned, produce yellow smoke and flames. Methods of producing the compositions are also disclosed. | 12-31-2009 |
| 20090320977 | PERCHLORATE-FREE RED SIGNAL FLARE COMPOSITION - Perchlorate-free flare compositions are disclosed which, when burned, produce red smoke and flames. Methods of producing the compositions are also disclosed. | 12-31-2009 |
| 20110132506 | PERCHLORATE-FREE RED SIGNAL FLARE COMPOSITION - Perchlorate-free flare compositions are disclosed which, when burned, produce red smoke and flames. Methods of producing the compositions are also disclosed. | 06-09-2011 |
| 20110139322 | PERCHLORATE-FREE YELLOW SIGNAL FLARE COMPOSITION - Perchlorate-free flare compositions are disclosed which, when burned, produce yellow smoke and flames. Methods of producing the compositions are also disclosed. | 06-16-2011 |
| Patent application number | Description | Published |
|---|
| 20090197827 | Combination Therapy for Treatment of FIV Infection - The present invention pertains to methods for therapeutic and prophylactic treatment of cats against FIV infection. Methods of the present invention utilize a combination of antiretroviral compounds to treat or prevent FIV infection in a feline animal. In one embodiment, the method comprises administering an effective amount of AZT and another nucleoside analog, such as, for example, 3TC to the animal. In another embodiment, cats are given an effective dose(s) of AZT, 3TC, and a retroviral protease inhibitor. | 08-06-2009 |
| 20090263417 | Multi-subtype FIV vaccines - The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. Methods for vaccinating cats with the subject vaccine compositions are also described. Cats vaccinated according to the methods and compositions of the subject invention exhibit protective humoral and cellular immune responses to FIV when challenged with homologous or heterologous strains of FIV. The subject invention also pertains to novel feline cell lines that are susceptible to infection by FIV and their methods of use. | 10-22-2009 |
| 20090274725 | Materials and Methods for Detecting, Preventing, and Treating Retroviral Infection - The subject invention pertains to materials and methods for detecting, preventing and treating retroviral infections in humans and other animals susceptible to infection by retrovirus. It has been discovered that FIV can be transmitted from cats to humans and that the FIV can infect human cells in vivo and that antibodies generated by the infected person cross-react with HIV antigens. Thus, the methods and compositions of the subject invention can be used to detect, prevent and treat FIV infection in humans and other non-feline animals that are susceptible to FIV infection. The methods and compositions of the invention can also be used to prevent and treat infection by HIV in humans. | 11-05-2009 |
| 20100111899 | Materials and Methods for Immunizing Against FIV Infection - The subject invention pertains to methods and compositions for protecting feline animals from infection by FIV using immunogens derived from primate immunodeficiency viruses, including HIV and SIV. Methods for vaccinating feline animals with the subject vaccine compositions are described. Feline animals vaccinated according to the methods and compositions of the subject invention exhibit protective humoral and cellular immune responses to FIV when challenged with FIV. | 05-06-2010 |
| 20120070489 | COMBINATION THERAPY FOR TREATMENT OF FIV INFECTION - The present invention pertains to methods for therapeutic and prophylactic treatment of cats against FIV infection. Methods of the present invention utilize a combination of antiretroviral compounds to treat or prevent FIV infection in a feline animal. In one embodiment, the method comprises administering an effective amount of AZT and another nucleoside analog, such as, for example, 3TC to the animal. In another embodiment, cats are given an effective dose(s) of AZT, 3TC, and a retroviral protease inhibitor. | 03-22-2012 |
| 20120294891 | MATERIALS AND METHODS FOR DETECTING, PREVENTING, AND TREATING RETROVIRAL INFECTION - The subject invention pertains to materials and methods for detecting, preventing and treating retroviral infections in humans and other animals susceptible to infection by retrovirus. It has been discovered that FIV can be transmitted from cats to humans and that the FIV can infect human cells in vivo and that antibodies generated by the infected person cross-react with HIV antigens. Thus, the methods and compositions of the subject invention can be used to detect, prevent and treat FIV infection in humans and other non-feline animals that are susceptible to FIV infection. The methods and compositions of the invention can also be used to prevent and treat infection by HIV in humans. | 11-22-2012 |
| Patent application number | Description | Published |
|---|
| 20090320249 | SLIDE FASTENER - Various embodiments of slide fasteners include a first set of coupling elements and a second set of coupling elements configured to be removably joined together by a zipper. Each coupling element includes a first surface having a first shape and a second surface having a second shape, wherein the second surface is spaced apart from and cofaces the first surface. The first shape may be substantially triangular or substantially trapezoidal, according to various embodiments, and the second shape is substantially gear shaped. When the coupling elements of the first set and the second set are removably joined together, water is substantially prevented from leaking from the first surface to the second surface. In addition, the coupling elements are disposed on stringer tapes, and the surfaces of the stringer tapes adjacent the first surfaces of the coupling elements are laminated with a water resistant material. | 12-31-2009 |
| 20090320250 | SLIDE FASTENER - Various embodiments of slide fasteners include a first set of coupling elements and a second set of coupling elements configured to be removably joined together by a slider. Each coupling element includes a first surface having a first shape and a second surface having a second shape, wherein the second surface is spaced apart from and cofaces the first surface. The first shape may be substantially triangular or substantially trapezoidal, according to various embodiments, and the second shape is substantially gear shaped. When the coupling elements of the first set and the second set are removably joined together, water is substantially prevented from leaking from the first surface to the second surface. In addition, the coupling elements are disposed on stringer tapes, and the surfaces of the stringer tapes adjacent the first surfaces of the coupling elements are laminated with a water resistant material. | 12-31-2009 |
| 20120260469 | Semi-Automatic Slider - A semi-automatic slider assembly comprising a slider body, a lock pin, and a pull tab. When the pull tab is in a first orientation, the lock pin engages with elements of the tape and the slider assembly is in a locked configuration that prevents the slider assembly from moving along the tape. When the pull tab is in a second orientation, the lock pin does not engage with the elements of the tape and the slider assembly is in an unlocked configuration so that the assembly is permitted to move along the tape. The slider body has a recess for receiving a portion of the lock pin, and the lock pin has an opening that reduces interference when the pull tab is in the second orientation. | 10-18-2012 |
| Patent application number | Description | Published |
|---|
| 20110156423 | PICK-UP STYLE UTILITY VEHICLE WITH EXPANDABLE CARGO BED - A pick-up style utility vehicle according to the present invention has a front seat, a rear seat, and a cargo bed in this order from front, a cabin frame surrounding a riding space, and a screen shield partitioning the cargo bed and a rear riding space in front of the cargo bed. The cargo bed can be changed between an expanded state in which the cargo bed is expanded in a front direction to the rear riding space and a non-expanded state not occupying the rear riding space. The screen shield is directly or indirectly supported by a swinging shaft provided on a vehicle body and is swingable between a position in the expanded state and a position in the non-expanded state. | 06-30-2011 |
| 20110156433 | PICK-UP STYLE UTILITY VEHICLE WITH EXPANDABLE CARGO BED - A pick-up style utility vehicle with an expandable cargo bed, the vehicle comprising a chassis, the chassis supporting a front seat, a rear seat, a screen formation, and a bottom plate of the cargo bed, wherein the pick-up style utility vehicle is capable to change a normal state in which the rear seat is situated on the bottom plate and an expanded state in which the cargo bed is expanded into a free space formed by shunting the rear seat from the top of the bottom plate, wherein the pick-up style utility vehicle comprises a screen formation between the cargo bed in the normal state and the rear seat, and comprises two screen formation divisions as a double door, and each of the screen formation division being supported rotatably around the vertical shaft by the chassis, wherein in the normal state, the two screen formation divisions closing the front of the cargo bed configure a screen in the normal state, the screen in the normal state separating between the rear seat and the cargo bed, wherein in the expanded state, the two screen formation divisions which open the front of the cargo bed configure expanded side plates in the cargo bed. | 06-30-2011 |
| 20110156441 | PICK-UP STYLE UTILITY VEHICLE WITH EXPANDABLE CARGO BED - A pick-up style utility vehicle according to the present invention has a front seat, a rear seat, and a cargo bed in this order from front, a cabin frame surrounding a riding space, and a screen shield partitioning the cargo bed and a rear riding space in front of the cargo bed. The cargo bed is changeable between an expanded state in which the cargo bed is expanded forward to the rear riding space and a non-expanded state not occupying the rear riding space. All or part of the screen shield is angle shiftable between the expanded state and the non-expanded state. | 06-30-2011 |
| 20120160592 | Utility Vehicle - A utility vehicle includes a vehicle body frame including a main frame to which an engine is mounted, the main frame including a round pipe having a circular cross-section and a rectangular pipe having a rectangular cross-section. | 06-28-2012 |
| Patent application number | Description | Published |
|---|
| 20080292489 | High Mn Austenitic Stainless Steel - An austenitic stainless steel alloy includes, in weight percent: >4 to 15 Mn; 8 to 15 Ni; 14 to 16 Cr; 2.4 to 3 Al; 0.4 to 1 total of at least one of Nb and Ta; 0.05 to 0.2 C; 0.01 to 0.02 B; no more than 0.3 of combined Ti+V; up to 3 Mo; up to 3 Co; up to 1W; up to 3 Cu; up to 1 Si; up to 0.05 P; up to 1 total of at least one of Y, La, Ce, Hf, and Zr; less than 0.05 N; and base Fe, wherein the weight percent Fe is greater than the weight percent Ni, and wherein the alloy forms an external continuous scale including alumina, nanometer scale sized particles distributed throughout the microstructure, the particles including at least one of NbC and TaC, and a stable essentially single phase FCC austenitic matrix microstructure that is essentially delta-ferrite-free and essentially BCC-phase-free. | 11-27-2008 |
| 20080304996 | High Nb, Ta, and Al Creep- and Oxidation-Resistant Austenitic Stainless Steels - An austenitic stainless steel HTUPS alloy includes, in weight percent: 15 to 30 Ni; 10 to 15 Cr; 2 to 5 Al; 0.6 to 5 total of at least one of Nb and Ta; no more than 0.3 of combined Ti+V; up to 3 Mo; up to 3 Co; up to 1 W; up to 0.5 Cu; up to 4 Mn; up to 1 Si; 0.05 to 0.15 C; up to 0.15 B; up to 0.05 P; up to 1 total of at least one of Y, La, Ce, Hf, and Zr; less than 0.05 N; and base Fe, wherein the weight percent Fe is greater than the weight percent Ni wherein said alloy forms an external continuous scale comprising alumina, nanometer scale sized particles distributed throughout the microstructure, said particles comprising at least one composition selected from the group consisting of NbC and TaC, and a stable essentially single phase fcc austenitic matrix microstructure, said austenitic matrix being essentially delta-ferrite-free and essentially BCC-phase-free. | 12-11-2008 |
| 20120301347 | CAST ALUMINA FORMING AUSTENITIC STAINLESS STEELS - An austenitic stainless steel alloy consisting essentially of, in terms of weight percent ranges 0.15-0.5C; 8-37Ni; 10-25Cr; 2.5-5Al; greater than 0.6, up to 2.5 total of at least one element selected from the group consisting of Nb and Ta; up to 3Mo; up to 3Co; up to 1W; up to 3Cu; up to 15Mn; up to 2Si; up to 0.15B; up to 0.05P; up to 1 total of at least one element selected from the group consisting of Y, La, Ce, Hf, and Zr; <0.3Ti+V; <0.03N; and, balance Fe, where the weight percent Fe is greater than the weight percent Ni, and wherein the alloy forms an external continuous scale comprising alumina, and a stable essentially single phase FCC austenitic matrix microstructure, the austenitic matrix being essentially delta-ferrite free and essentially BCC-phase-free. A method of making austenitic stainless steel alloys is also disclosed. | 11-29-2012 |
